Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

T lymphocytes as dynamic regulators of glioma pathobiology
Elizabeth Cordell, Mahmoud S. Alghamri, María G. Castro, et al.
Neuro-Oncology (2022) Vol. 24, Iss. 10, pp. 1647-1657
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Harmonized single-cell landscape, intercellular crosstalk and tumor architecture of glioblastoma
Cristian Ruiz-Moreno, Sergio Marco Salas, Erik Samuelsson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 83
Harnessing innate immune pathways for therapeutic advancement in cancer
An-Kang Hu, Li Sun, Hao Lin, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 51
Neutrophils: New Critical Regulators of Glioma
Guanyu Wang, Jinpeng Wang, Chaoshi Niu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
CAR T cells: engineered immune cells to treat brain cancers and beyond
Zoufang Huang, Saikat Dewanjee, Pratik Chakraborty, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 22
Therapeutic Strategies for Gliomas Associated With Cancer Predisposition Syndromes
Keng Lam, Carlos Kamiya-Matsuoka, John M. Slopis, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 6
Glioblastoma microenvironment—from biology to therapy
Renee Read, Zoe M. Tapp, Prajwal Rajappa, et al.
Genes & Development (2024)
Open Access | Times Cited: 6
Combined cytotoxic and immune-stimulatory gene therapy using Ad-TK and Ad-Flt3L: Translational developments from rodents to glioma patients
Syed Mohd Faisal, María G. Castro, Pedro R. Löwenstein
Molecular Therapy (2023) Vol. 31, Iss. 10, pp. 2839-2860
Open Access | Times Cited: 12
Advances in research on immune escape mechanism of glioma
Xu Guo, Gang Wang
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 7, pp. 1709-1720
Open Access | Times Cited: 11
Extracellular Matrix Structure and Interaction with Immune Cells in Adult Astrocytic Tumors
Anna Di Vito, Annalidia Donato, Jessica Bria, et al.
Cellular and Molecular Neurobiology (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 4
Role of T Lymphocytes in Glioma Immune Microenvironment: Two Sides of a Coin
Lubna Noor, Arun Upadhyay, Vibhuti Joshi
Biology (2024) Vol. 13, Iss. 10, pp. 846-846
Open Access | Times Cited: 3
Advances in CAR-T therapy for central nervous system tumors
Delian Zhou, Xiaojian Zhu, Yi Xiao
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Immune Landscape in PTEN-Related Glioma Microenvironment: A Bioinformatic Analysis
Alice Giotta Lucifero, Sabino Luzzi
Brain Sciences (2022) Vol. 12, Iss. 4, pp. 501-501
Open Access | Times Cited: 15
Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy
Volker Schirrmacher, Stefaan Van Gool, Wilfried Stuecker
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13050-13050
Open Access | Times Cited: 15
Biomimetic nanoparticles for tumor immunotherapy
Hanqing Yu, Meng–Huang Wu, Siyu Chen, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 14
EGFR alterations in glioblastoma play a role in antitumor immunity regulation
Xiaopeng Li, Zheng‐Qian Guo, Baofeng Wang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Multifunctional Photonic Nanomaterials and Devices for Digital Photomedicine via Neuro‐Immune Cross‐Talks
Seong‐Jong Kim, Tae‐Yeon Kim, H. Kim, et al.
Advanced Materials (2024)
Closed Access | Times Cited: 2
B7-H4 reduces the infiltration of CD8+T cells and induces their anti-tumor dysfunction in gliomas
Ying Qi, Lang Hu, Chunxia Ji, et al.
Neoplasia (2024) Vol. 54, pp. 101007-101007
Open Access | Times Cited: 1
Insights of immune cell heterogeneity, tumor-initiated subtype transformation, drug resistance, treatment and detecting technologies in glioma microenvironment
Tongzheng Chen, Wenbin Ma, Xin Wang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 1
Implications of CRNDE in prognosis, tumor immunity, and therapeutic sensitivity in low grade glioma patients
Yang Chen, Ying-chuan Jiang, Fan Hu, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Identification and Validation of TEAD Family’s Prognostic Effects and Immune Microenvironment Regulations in Glioma
Zhengyuan Huo, Shaorui Gu, Zheng Bian, et al.
International Journal of Clinical Practice (2024) Vol. 2024, Iss. 1
Open Access
Applications of artificial intelligence in the analysis of histopathology images of gliomas: a review
Jan-Philipp Redlich, Friedrich Feuerhake, Joachim Weis, et al.
npj Imaging (2024) Vol. 2, Iss. 1
Open Access
Glioma immune microenvironment composition calculator (GIMiCC): a method of estimating the proportions of eighteen cell types from DNA methylation microarray data
Steven C. Pike, John K. Wiencke, Ze Zhang, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access
Human single cell RNA-sequencing reveals a targetable CD8+ exhausted T cell population that maintains mouse low-grade glioma growth
Rasha Barakat, Jit Chatterjee, Rui Mu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Engineering the glioblastoma microenvironment using TLR7/8 agonist-complexed graphene oxide nanosheets
Maria Stylianou, Thomas Kisby, Despoina Despotopoulou, et al.
Cell Reports Physical Science (2024), pp. 102342-102342
Open Access
Cellular Components of the Tumor Environment in Gliomas—What Do We Know Today?
Reinhold Nafe, Elke Hattingen
Biomedicines (2023) Vol. 12, Iss. 1, pp. 14-14
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top